Clinical trial
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
NCT00277641 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00277641 |
|---|---|
| Title | Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity |
| Official title | Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity: A Single-Center, Double-Blind, Placebo-Controlled, Flexible-Dose Study in Outpatients |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | GlaxoSmithKline Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Binge Eating Disorder, Obesity |
| Intervention type | Drug |
| Interventions | Lamotrigine, placebo |
| Enrollment | 70 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 16, 2006 |
| Last update posted | Jun 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: